title: Hypothalamic corticotrophin-releasing factor and norepinephrine mediate sympathetic and cardiovascular responses to acute intracarotid injection of tumour necrosis factor-alpha in the rat.
abstract: Systemic administration of tumour necrosis factor (TNF)-alpha induces the release of norepinephrine in the paraventricular nucleus (PVN) of hypothalamus and an increase in expression of corticotrophin-releasing factor (CRF) and CRF type 1 receptors. We explored the hypothesis that CRF and norepinephrine in PVN mediate the cardiovascular and sympathetic responses to acute systemic administration of TNF-alpha. In anaesthetised rats, the increases in arterial pressure and heart rate induced by intracarotid artery injection of TNF-alpha were attenuated by intracerebroventricular (ICV) injection of either the alpha 1-adrenergic antagonist prazosin or the CRF antagonist alpha-helical CRF. Prazosin blocked the TNF-alpha-induced increase in renal sympathetic nerve activity (RSNA), whereas alpha-helical CRF substantially reduced the RSNA response. Conversely, CRF and the alpha 1-adrenergic agonist phenylephrine, administered ICV, both elicited increases in PVN neuronal activity, RSNA, arterial pressure and heart rate. Microinjection of CRF and phenylephrine directly into PVN evoked smaller responses. These results are consistent with the hypothesis that norepinephrine and CRF in the PVN mediate the cardiovascular and sympathetic responses to acute systemic administration of TNF-alpha.
authors.affiliation: Department of Internal Medicine, University of Iowa, Iowa, IA 52242, USA.
authors.forename: Z-H
authors.initials: ZH
authors.lastname: Zhang
authors.forename: R B
authors.initials: RB
authors.lastname: Felder
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002316:Cardiotonic Agents / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects* / Q000378:metabolism; D002339:Carotid Arteries / Q000187:drug effects; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007269:Injections, Intra-Arterial; D007276:Injections, Intraventricular; D008297:Male; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D010656:Phenylephrine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000959:Antihypertensive Agents; D002316:Cardiotonic Agents; D014409:Tumor Necrosis Factor-alpha; D010656:Phenylephrine; D003346:Corticotropin-Releasing Hormone; D009638:Norepinephrine; D011224:Prazosin
references.citation: Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10
references.pmid: 15173056
references.citation: Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H423-33
references.pmid: 12063317
references.citation: Eur Heart J. 2005 Feb;26(4):357-62
references.pmid: 15618038
references.citation: J Neuroimmunol. 1996 Nov;70(2):163-79
references.pmid: 8898725
references.citation: Fed Proc. 1985 Jan;44(1 Pt 2):243-8
references.pmid: 2981744
references.citation: Endocrinology. 1994 Nov;135(5):2177-82
references.pmid: 7956940
references.citation: J Physiol. 1979 Mar;288:159-69
references.pmid: 469713
references.citation: Proc Soc Exp Biol Med. 2000 Jan;223(1):22-38
references.pmid: 10632958
references.citation: J Comp Neurol. 2000 Dec 4;428(1):5-20
references.pmid: 11058221
references.citation: Psychoneuroendocrinology. 1996 Jan;21(1):83-93
references.pmid: 8778906
references.citation: J Neurosci. 2002 Jul 1;22(13):5606-18
references.pmid: 12097512
references.citation: Circulation. 2002 Mar 5;105(9):1135-43
references.pmid: 11877368
references.citation: Neurochem Int. 2008 May;52(6):1220-5
references.pmid: 18280616
references.citation: Clin Chim Acta. 1999 Feb;280(1-2):127-34
references.pmid: 10090530
references.citation: Am J Cardiol. 1997 Dec 4;80(11A):26L-40L
references.pmid: 9412540
references.citation: J Appl Physiol (1985). 2006 Apr;100(4):1392-9
references.pmid: 16322371
references.citation: Brain Res Mol Brain Res. 1996 May;38(1):166-70
references.pmid: 8737681
references.citation: Minerva Endocrinol. 2004 Jun;29(2):47-54
references.pmid: 15257255
references.citation: J Neuroendocrinol. 2005 Aug;17(8):498-508
references.pmid: 16011486
references.citation: Ciba Found Symp. 1993;172:5-21; discussion 21-9
references.pmid: 8491094
references.citation: Brain Behav Immun. 2008 May;22(4):573-89
references.pmid: 18191534
references.citation: Hum Psychopharmacol. 2004 Aug;19(6):397-403
references.pmid: 15303243
references.citation: Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H923-4
references.pmid: 16467462
references.citation: Ann N Y Acad Sci. 2000;917:38-67
references.pmid: 11268364
references.citation: Neuroendocrinology. 1987 Aug;46(2):143-6
references.pmid: 2819759
references.citation: Circulation. 1998 Sep 29;98(13):1329-34
references.pmid: 9751683
references.citation: J Comp Neurol. 1993 Jul 8;333(2):151-67
references.pmid: 7688383
references.citation: J Neurochem. 2000 May;74(5):2134-45
references.pmid: 10800959
references.citation: Eur Heart J. 2001 Jul;22(13):1136-43
references.pmid: 11428854
references.citation: Circulation. 2001 Apr 24;103(16):2055-9
references.pmid: 11319194
references.citation: Panminerva Med. 2005 Jun;47(2):75-80
references.pmid: 16210992
references.citation: Circ Res. 2002 Nov 29;91(11):988-98
references.pmid: 12456484
references.citation: Pharmacol Rev. 2000 Dec;52(4):595-638
references.pmid: 11121511
references.citation: Endocrinology. 1996 Nov;137(11):4619-29
references.pmid: 8895325
references.citation: Ann N Y Acad Sci. 2000;917:608-17
references.pmid: 11268389
references.citation: Front Biosci. 2003 Sep 01;8:s1321-9
references.pmid: 12957837
references.citation: Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H890-5
references.pmid: 11834483
references.citation: Am J Physiol Regul Integr Comp Physiol. 2002 Aug;283(2):R281-3
references.pmid: 12121837
references.citation: Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):551-9
references.pmid: 12172480
references.citation: Physiol Rev. 1994 Apr;74(2):323-64
references.pmid: 8171117
references.citation: Brain Res. 1987 Dec 29;437(2):253-63
references.pmid: 3325130
references.citation: Acta Physiol Scand. 2003 Mar;177(3):209-18
references.pmid: 12608991
references.citation: J Neurosci. 2002 Feb 1;22(3):959-69
references.pmid: 11826124
references.citation: J Neurosci. 1997 Sep 15;17(18):7166-79
references.pmid: 9278551
references.citation: J Neuroendocrinol. 1994 Dec;6(6):689-96
references.pmid: 7894472
references.citation: J Neurosci. 1995 Apr;15(4):2680-95
references.pmid: 7722622
references.citation: Ciba Found Symp. 1993;172:243-53; discussion 253-7
references.pmid: 8491089
references.citation: Cytokine. 2004 Oct 21;28(2):87-91
references.pmid: 15381186
references.citation: Am J Physiol Regul Integr Comp Physiol. 2003 Apr;284(4):R916-27
references.pmid: 12626358
references.citation: Prog Brain Res. 1982;57:267-77
references.pmid: 6296919